Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk

Byron J Hoogwerf, Krupa B Doshi, Dima Diab

Vascular Health and Risk Management 2008, 4:355-362

Published Date: 11 April 2008